«ΨΥΧΟΛΟΓΙΑ έρευνα & εφαρμογές» Τόμος 1, Τεύχος 3, 2018 ISSN: 2623-3673
Committee of the American College of Gastroenterology. Alcoholic liver disease.
Hepatology 2010; 51(1): 307–328
Oshita M, Hayashi N, Kasahara A, Hagiwara H, Mita E, Naito M, Katayama K,
Fusamoto H, Kamada T. Increased serum hepatitis C virus RNA levels among
alcoholic patients with chronic hepatitis C. Hepatology 1994; 20: 1115–1120
Oslin D. Late-life alcoholism: issues relevant to the geriatric psychiatrist. Am J Geriatr
Psychiatry 2004; 12(6): 571–583
Pares A, Barrera JM, Caballeria J, Ercilla G, Bruguera M, Caballeria L, Castillo R,
Rodes J. Hepatitis C virus antibodies in chronic alcoholic
patients: association with severity of liver injury. Hepatology 1990; 12: 1295–1299
Pearl R. Alcohol and life duration. BMJ 1924; 1: 948–950
Pessione F, Degos F, Marcellin P, Duchatelle V, Njapoum C, Martinot-Peignoux M,
Degott C, Valla D, Erlinger S, Rueff B. Effect of alcohol consumption on serum
hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology
1998; 27: 1717–1722
Pessione F, Ramond MJ, Peters L, et al. Five-year survival predictive factors in
patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis,
smoking and abstinence. Liver Int 2003; 23(1): 45–53
Poynard T, Bedossa P, Opolon. Natural history of liver fibrosis progression in
patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and
DOSVIRC groups. Lancet 1997; 349: 825–832
Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease.
Hepatology 2009; 50(2): 638–644